The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 clinical trial of durvalumab in children with solid and central nervous system tumors.
 
Leo Mascarenhas
Consulting or Advisory Role - Amgen; Bayer (Inst)
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); E.R. Squibb Sons, LLC (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
(OPTIONAL) Uncompensated Relationships - Children's Oncology Group Foundation; The Pablove Foundation
 
Abrahm Levi
Stock and Other Ownership Interests - Moderna Therapeutics; Sorrento Therapeutics
 
Jemily Malvar
No Relationships to Disclose
 
Josephine Hoatuyet Haduong
No Relationships to Disclose
 
Yu Jiang
Employment - AstraZeneca Canada
Stock and Other Ownership Interests - AstraZeneca Canada
 
Sarah E. Donegan
Employment - AstraZeneca Canada
Stock and Other Ownership Interests - AstraZeneca Canada
 
Anat Erdreich-Epstein
No Relationships to Disclose
 
Nathan John Robison
No Relationships to Disclose
 
Weifeng Tang
Employment - AstraZeneca Canada
Stock and Other Ownership Interests - AstraZeneca Canada
 
Yueh-Yun Chi
No Relationships to Disclose
 
Fariba Navid
Research Funding - Bayer (Inst)